Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAR-T Cells in Cervical Cancer
NCT03356795Phase 2Terminated
- Sponsor
- Shenzhen Geno-Immune Medical Institute
- Start
- Jun 2026
- Primary completion
- Jul 2026
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of Cervical cancer-specific CAR-T cells in Cervical Cancer (CC), sponsored by Shenzhen Geno-Immune Medical Institute. Started Jun 2026; status: terminated.
02
Drugs
Cervical cancer-specific CAR-T cells
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT03356795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03356795.